Pluri Inc. Operating Lease Liability
Pluri Inc. (PLUR) had Operating Lease Liability of $7.48 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-09-10
- 2026-06-30: Operating Lease, Liability $7.48M.
- 2025-06-30: Operating Lease, Liability $6.76M.
- 2024-06-30: Operating Lease, Liability $5.58M.
- 2023-06-30: Operating Lease, Liability $6.38M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $7.48M 10-K · filed 2026-09-10 |
| 2025-06-30 | $6.76M 10-K · filed 2026-09-10 |
| 2024-06-30 | $5.58M 10-K · filed 2025-09-17 |
| 2023-06-30 | $6.38M 10-K · filed 2024-09-18 |
| 2022-06-30 | $7.12M 10-K · filed 2023-09-12 |
| 2021-06-30 | $734.00K 10-K · filed 2022-09-21 |
| 2020-06-30 | $1.58M 10-K · filed 2021-09-13 |
| 2020-03-31 | $1.78M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $2.00M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $2.23M 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |